Humanoid Robots Hit the Public Markets — and the Hype Meets Its First Earnings Test

In the span of two weeks, three humanoid robot companies moved toward public markets: Unitree cleared its Shanghai STAR Market IPO at a valuation above $14 billion, Agility Robotics announced a $2.5 billion SPAC to become the first US-listed pure-play humanoid maker, and Tesla began converting a Fremont line for Optimus with a designed capacity of one million units a year.

It looks like a coronation. Read the filings, and it looks more like an examination.

What the prospectuses actually say

Unitree's IPO documents tell a more complicated story than the 30-plus robot-concept stocks that hit their daily limit on its approval would suggest. First-quarter revenue growth decelerated sharply to 68 percent — spectacular for most industries, a warning sign for a company priced as a hypergrowth story. Net profit halved year-over-year, and the prospectus explicitly names price competition from Tesla and Chinese automakers as a structural risk.

Tesla, meanwhile, quietly confirmed that every Optimus built in 2026 stays in-house for testing and data collection. The million-unit line is real; the million-unit market is not, yet.

Agility is the outlier with $300 million in booked orders — genuine commercial traction, but a number that must now grow under quarterly scrutiny rather than venture patience.

From theme to verification

The pattern mirrors what happened to Asian AI stocks more broadly this month, when Samsung posted a record profit outlook and still fell nearly 7 percent: capital has stopped rewarding the label and started demanding the earnings. Robot-concept rallies in Shanghai still happen — Unitree's registration proved that — but the durable money is rotating toward companies with visible near-term catalysts and defensible unit economics.

For humanoids, the honest accounting is stark. Hardware costs remain punishing, reliability in unstructured environments is unproven, and the largest player has effectively told the market that external sales are a 2027 story.

Why China still holds the strong hand

None of this means the skeptics win. China's advantages — a dense supplier ecosystem that has already crushed actuator and sensor costs, state procurement programs, and factories willing to serve as live training environments — map directly onto the sector's bottlenecks. Unitree's halved margins partly reflect a price war that Chinese firms are choosing to fight because they can outlast almost everyone else in it.

The public listings will force the discipline the sector has lacked: audited unit shipments, disclosed order books, real margins. Eighteen months from now we will know whether humanoid robotics in 2026 was semiconductor-style infrastructure buildout — early, volatile, ultimately foundational — or the metaverse with legs. The filings, for the first time, will tell us.